572 related articles for article (PubMed ID: 16877463)
1. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
[TBL] [Abstract][Full Text] [Related]
2. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
3. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.
Nagata K; Tomii K; Otsuka K; Tachikawa R; Otsuka K; Takeshita J; Tanaka K; Matsumoto T; Monden K
Respirology; 2012 Apr; 17(3):506-12. PubMed ID: 22257381
[TBL] [Abstract][Full Text] [Related]
5. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
[TBL] [Abstract][Full Text] [Related]
6. Clinical determinants of the 6-Minute Walk Test in bronchiectasis.
Lee AL; Button BM; Ellis S; Stirling R; Wilson JW; Holland AE; Denehy L
Respir Med; 2009 May; 103(5):780-5. PubMed ID: 19070473
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
8. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
[TBL] [Abstract][Full Text] [Related]
9. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
[TBL] [Abstract][Full Text] [Related]
10. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
[TBL] [Abstract][Full Text] [Related]
12. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
Johnson SR; Glaman DD; Schentag CT; Lee P
J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
[TBL] [Abstract][Full Text] [Related]
14. Impact of pain in health related quality of life of patients with systemic sclerosis.
Georges C; Chassany O; Toledano C; Mouthon L; Tiev K; Meyer O; Ilie D; Rambeloarisoa J; Marjanovic Z; Cabane J; Sereni D; Pouchot J; Farge D
Rheumatology (Oxford); 2006 Oct; 45(10):1298-302. PubMed ID: 16754629
[TBL] [Abstract][Full Text] [Related]
15. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
[TBL] [Abstract][Full Text] [Related]
16. Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.
Wallace B; Kafaja S; Furst DE; Berrocal VJ; Merkel PA; Seibold JR; Mayes MD; Khanna D
Rheumatology (Oxford); 2015 Aug; 54(8):1369-79. PubMed ID: 25667436
[TBL] [Abstract][Full Text] [Related]
17. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
[TBL] [Abstract][Full Text] [Related]
18. [Relation between pulmonary ventilation parameters, exercise tolerance and quality of life in patients with chronic obstructive lung disease].
Chlumský J; Stĕrbová L; Smolíková L; Matous M; Salajka F
Vnitr Lek; 2002 Apr; 48(4):320-4. PubMed ID: 12061182
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of the visual analogue scale 8 in measuring health-related quality of life for COPD patients.
Nishiyama O; Taniguchi H; Kondoh Y; Nishimura K; Suzuki R; Takagi K; Yamaki K
Respir Med; 2000 Dec; 94(12):1192-9. PubMed ID: 11192955
[TBL] [Abstract][Full Text] [Related]
20. Using a self-reported functional score to assess disease progression in systemic sclerosis.
Serednicka K; Smyth AE; Black CM; Denton CP
Rheumatology (Oxford); 2007 Jul; 46(7):1107-10. PubMed ID: 17426141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]